BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3330600)

  • 21. A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice.
    Crawford RJ; Allman S; Gibson W; Kitchen S; Richards HH
    J Int Med Res; 1988; 16(2):143-9. PubMed ID: 3378660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of cardiac insufficiency with diuretics].
    Holzgreve H
    Fortschr Med; 1982 Aug; 100(31-32):1449-56. PubMed ID: 7129304
    [No Abstract]   [Full Text] [Related]  

  • 23. Life-threatening hyperkalaemia in an elderly patient receiving captopril, furosemide (frusemide) and potassium supplements.
    Chan TY; Critchley JA
    Drug Saf; 1992; 7(2):159-61. PubMed ID: 1605901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values].
    Cserhalmi L
    Orv Hetil; 1998 Jan; 139(2):63-6. PubMed ID: 9451904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the need for potassium supplementation in patients subjected to furosemide therapy].
    Jardim PC; Branco RF; Silva EG
    Arq Bras Cardiol; 1988 Aug; 51(2):153-6. PubMed ID: 3075113
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of drugs on a noninvasive index of arterial compliance in healthy and heart failure patients.
    Domingo E; Gilabert MR; Alio J; Angel J; Soler-Soler J
    Cathet Cardiovasc Diagn; 1991 Oct; 24(2):93-8. PubMed ID: 1742791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of aldosterone on sodium and potassium metabolism in congestive cardiac failure.
    Peltola P
    Ann Clin Res; 1969 Dec; 1(4):286-90. PubMed ID: 5371915
    [No Abstract]   [Full Text] [Related]  

  • 28. Atenolol improves blood pressure control in patients taking captopril and frusemide.
    Potter JF; Beevers DG
    J Hum Hypertens; 1987 Sep; 1(2):127-30. PubMed ID: 3333524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of captopril in relieving congestive heart failure developing during management of hypertension. Case report.
    McNay JL; Dole WP
    Hypertension; 1983; 5(3):390-3. PubMed ID: 6341222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
    Ferreira SR; Saragoça MA; Homsi E; Ajzen H; Draibe SA; Ribeiro AB; Ramos OL
    J Clin Hypertens; 1987 Dec; 3(4):685-94. PubMed ID: 3330991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart attack patients with complications. Treat with valsartan, captopril, or both?
    Nguyen A; Sharma S
    Can Fam Physician; 2004 Aug; 50():1093-5. PubMed ID: 15455807
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
    Le Pailleur C; Baubion N; Metzger JP; Heulin A; Vacheron A; Di Matteo J
    Arch Mal Coeur Vaiss; 1984 Jun; 77(6):700-6. PubMed ID: 6431936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effective blood pressure reduction and few side-effects in treatment with captopril and diuretics].
    Nilsson O; Karlberg BE; Wettre S; Ohman P; Andersson PO; Engström M; Kuylenstierna J; Ottosson AM; Sjöstrand A
    Lakartidningen; 1985 Jun; 82(26-27):2430-3. PubMed ID: 3892203
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of hypertensive crisis with captopril].
    Biollaz J; Waeber B; Turini GA; Schaller MD; Brunner HR
    Schweiz Med Wochenschr; 1983 Dec; 113(52):2006-7. PubMed ID: 6364338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of heart failure with combined furosemide retard/triamterene].
    Burkhardt H; Graul EH; Pfab R; Schuster O; Loew D
    Fortschr Med; 1984 Jul; 102(27-28):735-9. PubMed ID: 6479817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide.
    Webster J; Petrie JC; Robb OJ; Witte K; Lovell HG
    J Hum Hypertens; 1987 Sep; 1(2):121-6. PubMed ID: 3333523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Magnesium and potassium levels in the blood serum and lymphocytes and the rate of sodium outflow through lymphocyte membranes in patients with chronic heart failure].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1992 Jun 1-8; 47(22-23):487-9. PubMed ID: 1437775
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
    Burnakis TG; Mioduch HJ
    Arch Intern Med; 1984 Dec; 144(12):2371-2. PubMed ID: 6391404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term captopril therapy in severe congestive heart failure.
    Kaushik SK; Kaul U; Malhotra A; Gopinath PG; Bhatia ML
    J Assoc Physicians India; 1986 Jun; 34(6):399-403. PubMed ID: 3533898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.